Andilum, Baby Girl .

HRN: 21-99-02  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2022
CEFTAZIDIME 1GM (VIAL)
09/23/2022
09/29/2022
IV
27mg
Q12
Neonatal Sepsis
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Disseminated Systemic Infection    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: